Cite
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
MLA
Dekervel, Jeroen, et al. “Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response.” Translational Oncology, vol. 10, no. 1, Feb. 2017, pp. 59–69. EBSCOhost, https://doi.org/10.1016/j.tranon.2016.11.008.
APA
Dekervel, J., Bulle, A., Windmolders, P., Lambrechts, D., Van Cutsem, E., Verslype, C., & van Pelt, J. (2017). Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response. Translational Oncology, 10(1), 59–69. https://doi.org/10.1016/j.tranon.2016.11.008
Chicago
Dekervel, Jeroen, Ashenafi Bulle, Petra Windmolders, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, and Jos van Pelt. 2017. “Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response.” Translational Oncology 10 (1): 59–69. doi:10.1016/j.tranon.2016.11.008.